A two-SNP IL-6 promoter haplotype is associated with increased lung cancer risk

[1]  N. Yi,et al.  Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals. , 2012, Experimental and therapeutic medicine.

[2]  M. Pan,et al.  Interleukin 6 Promoter Polymorphisms in Normal Han Chinese Population , 2011, Journal of Investigative Medicine.

[3]  Kevin Struhl,et al.  STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. , 2010, Molecular cell.

[4]  A. Kazlauskas.  Faculty Opinions recommendation of An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. , 2010 .

[5]  T. Seeman,et al.  Computational identification of gene-social environment interaction at the human IL6 locus , 2010, Brain, Behavior, and Immunity.

[6]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[7]  A. Singleton,et al.  Genomewide association studies and human disease. , 2009, The New England journal of medicine.

[8]  Kevin Struhl,et al.  An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation , 2009, Cell.

[9]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[10]  R. Wolff,et al.  Tumor markers and rectal cancer: Support for an inflammation‐related pathway , 2009, International journal of cancer.

[11]  Kui Zhang,et al.  TGFBR1 haplotypes and risk of non-small-cell lung cancer. , 2009, Cancer research.

[12]  S. Land,et al.  Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non–Small Cell Lung Cancer among Women , 2009, Cancer Epidemiology Biomarkers & Prevention.

[13]  S. Imbeaud,et al.  Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours , 2009, Nature.

[14]  Yulia V. Marchenko,et al.  Semiparametric Analysis of Case–control Genetic Data in the Presence of Environmental Factors , 2008 .

[15]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[16]  C. Ulrich,et al.  Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.

[17]  S. Humphries,et al.  Association of serum interleukin-6 concentration with a functional IL6 -6331T>C polymorphism. , 2008, Clinical chemistry.

[18]  D. Du,et al.  Identification of interleukin-6 promoter polymorphisms in the Chinese Han population and their functional significance* , 2008, Critical care medicine.

[19]  Francis S Collins,et al.  A HapMap harvest of insights into the genetics of common disease. , 2008, The Journal of clinical investigation.

[20]  H. Oral,et al.  The involvement of IL‐10, IL‐6, IFN‐γ, TNF‐α and TGF‐β gene polymorphisms among Turkish lung cancer patients , 2008, Cell biochemistry and function.

[21]  M. Karin,et al.  Autocrine IL-6 signaling: a key event in tumorigenesis? , 2008, Cancer cell.

[22]  W. Gerald,et al.  Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. , 2007, The Journal of clinical investigation.

[23]  M. Spitz,et al.  Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. , 2007, Cancer research.

[24]  Heike Knüpfer,et al.  Significance of interleukin-6 (IL-6) in breast cancer (review) , 2007, Breast Cancer Research and Treatment.

[25]  W. Poh,et al.  Joint effect of asthma/atopy and an IL-6 gene polymorphism on lung cancer risk among lifetime non-smoking Chinese women. , 2006, Carcinogenesis.

[26]  D. Zeng,et al.  Likelihood-Based Inference on Haplotype Effects in Genetic Association Studies , 2006 .

[27]  Astrid Dempfle,et al.  TNF-α, TNF-β, IL-6, and IL-10 Polymorphisms in Patients with Lung Cancer , 2005, Disease markers.

[28]  E. Hurt,et al.  The role of IL-6 and STAT3 in inflammation and cancer. , 2005, European journal of cancer.

[29]  Raymond J Carroll,et al.  Analysis of case‐control studies of genetic and environmental factors with missing genetic information and haplotype‐phase ambiguity , 2005, Genetic epidemiology.

[30]  S. Humphries,et al.  Novel IL-6 haplotypes and disease association , 2005, Genes and Immunity.

[31]  P. Brennan,et al.  Lack of Association between Polymorphisms in Inflammatory Genes and Lung Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[32]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[33]  M. Gazouli,et al.  The interleukin-6-174 promoter polymorphism is associated with a risk of development of Kaposi's sarcoma in renal transplant recipients. , 2004, Anticancer research.

[34]  Vidar Skaug,et al.  Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. , 2003, Carcinogenesis.

[35]  Stefano Landi,et al.  Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. , 2003, Cancer research.

[36]  T. Yoshikawa,et al.  Interleukin‐6 polymorphism (–634C/G) in the promotor region and the progression of diabetic nephropathy in Type 2 diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[37]  C. Ahn,et al.  The --174 G to C polymorphism of interleukin-6 gene is very rare in koreans. , 2002, Cytokine.

[38]  A. Mander,et al.  Haplotype Analysis in Population-based Association Studies , 2001 .

[39]  D. Christiani,et al.  The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population. , 2001, Pharmacogenetics.

[40]  Frank Dudbridge,et al.  Haplotype tagging for the identification of common disease genes , 2001, Nature Genetics.

[41]  M. Xiong,et al.  Haplotypes vs single marker linkage disequilibrium tests: what do we gain? , 2001, European Journal of Human Genetics.

[42]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[43]  E. Mariman,et al.  Promoter haplotype combinations of the platelet-derived growth factor α-receptor gene predispose to human neural tube defects , 2001, Nature Genetics.

[44]  M. Hierholzer,et al.  TRANSFORMATION , 2001, Human Rights: Universality and Diversity.

[45]  N. Schork,et al.  Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. , 2000, American journal of human genetics.

[46]  S. Steinberg,et al.  An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. , 2000, Blood.

[47]  F. Green,et al.  Cooperative Influence of Genetic Polymorphisms on Interleukin 6 Transcriptional Regulation* , 2000, The Journal of Biological Chemistry.

[48]  T. Nakajima,et al.  Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women , 1999, Genes and Immunity.

[49]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[50]  J S Yudkin,et al.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.

[51]  G. Clayman,et al.  Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: possible influence of p53 but not human papillomavirus E6/E7. , 1998, Cancer research.

[52]  J. Ferlay,et al.  Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[53]  J. Darnell,et al.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.

[54]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[55]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[56]  T. Kishimoto.  Interleukin-6: from basic science to medicine--40 years in immunology. , 2005, Annual review of immunology.

[57]  R. Oyasu,et al.  Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. , 1997, Cancer research.